Abstract: The present disclosure relates to a compound or its salt thereof targeting fibroblast activation protein, its preparation methods and uses, especially the compound represented by formula (I) D-R1-R2-A-R? or its salt thereof, and its preparation methods and its uses.
Type:
Grant
Filed:
March 9, 2022
Date of Patent:
August 29, 2023
Assignee:
INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, R.O.C.